Link to this page
Medical Subject Headings
Last uploaded:
August 28, 2024
Jump to:
| Preferred Name | safinamide | |
| Synonyms |
FCE 28073 PNU-151774E Xadago PNU 151774E safinamide methanesulfonate NW-1015 FCE-28073 2-(4-(3-fluorobenzyloxy)benzylamino)propionamide FCE 26743 fbap methanesulfonate FCE-26743 (S)-2-((4-(3-fluorobenzoxy)benzyl)amino)propanamide |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C092797 |
|
| altLabel |
FCE 28073 PNU-151774E Xadago PNU 151774E safinamide methanesulfonate NW-1015 FCE-28073 2-(4-(3-fluorobenzyloxy)benzylamino)propionamide FCE 26743 fbap methanesulfonate FCE-26743 (S)-2-((4-(3-fluorobenzoxy)benzyl)amino)propanamide
|
|
| cui |
C0295934 C4475895 C0754124 C3642425 C0380413 C3642426 C1098261
|
|
| Has mapping qualifier | ||
| HM |
D000409/Q000031 D001596
|
|
| Inverse of RB |
YS90V3DTX0 90ENL74SIG 0
|
|
| LT |
TRD
|
|
| Mapped to | ||
| MDA |
19950428
|
|
| MeSH Frequency |
134
|
|
| MMR |
20191030
|
|
| notation |
C092797
|
|
| prefLabel |
safinamide
|
|
| RR |
YS90V3DTX0 133865-89-1 (safinamide)
|
|
| SC |
1
|
|
| Scope Statement |
short-acting inhibitor of MOA-B; FCE 26743 is (S)-isomer, FCE 28073 is (R)-isomer; structure in first source
|
|
| SRC |
J Pharm Pharmacol 1994 Oct;46(10):814-9
|
|
| TERMUI |
T274895 T274890 T000993865 T467683 T274897 T274894 T274892 T274893 T274896 T831173 T274889 T000881760 T274891
|
|
| TH |
NLM (1995) NLM (2020) FDA SRS (2013) NLM (2015) NLM (2001) INN (19XX) NLM (2013)
|
|
| tui |
T109 T121
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping